Related references
Note: Only part of the references are listed.CSF tau correlates with CJD disease severity and cognitive decline
O. S. Cohen et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Clinical findings and diagnosis in genetic prion diseases in Germany
Anna Krasnianski et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic
Matthias Schmitz et al.
MOLECULAR NEUROBIOLOGY (2016)
Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia
Franc Llorens et al.
ALZHEIMERS & DEMENTIA (2016)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
Katharina Stoeck et al.
BRAIN (2012)
Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study
Michael B. Coulthart et al.
BMC NEUROLOGY (2011)
Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease
Gianluigi Zanusso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel
Zeev Meiner et al.
JOURNAL OF NEUROLOGY (2011)
Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease
Moeko Noguchi-Shinohara et al.
JOURNAL OF NEUROLOGY (2011)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review
G. Chohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients
Ines Esteves Baldeiras et al.
JOURNAL OF NEUROLOGY (2009)
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
Anna Ladogana et al.
JOURNAL OF NEUROLOGY (2009)
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
Anders Skinningsrud et al.
FLUIDS AND BARRIERS OF THE CNS (2008)
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
Pascual Sanchez-Juan et al.
JOURNAL OF NEUROLOGY (2007)
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
S. J. Collins et al.
BRAIN (2006)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan
K Satoh et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Highly increased CSF tau protein and decreased β-amyloid (1-42) in sporadic CJD:: a discrimination from Alzheimer's disease?
E Kapaki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease
I Zerr et al.
NEUROLOGY (2000)
Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2000)
Share Paper
